Nicorandil derivatives
HK40067812BActive Publication Date: 2026-09-11UNICYCIVE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- HK62022056980
- Authority / Receiving Office
- HK · HK
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-03-15
- Filing Date
- 2022-07-19
- Publication Date
- 2026-09-11
AI Technical Summary
Technical Problem
Current treatments for kidney diseases such as Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), and Acute Kidney Failure are often irreversible and require dialysis or transplant, with limited effective pharmaceutical options available.
Method used
Development of pyridyl compounds, including nicorandil derivatives, which can be administered to treat kidney-related conditions by forming nicorandil in vivo, targeting specific kidney diseases and conditions.
Benefits of technology
The compounds effectively prevent, treat, or ameliorate kidney diseases and conditions, including CKD, diabetic nephropathy, and various types of AKI, offering therapeutic benefits without the need for irreversible treatments like transplant.
✦ Generated by Eureka AI based on patent content.
Smart Images

Figure 00000056_0000 
Figure 00000057_0000
Need to check novelty before this filing date? Find Prior Art
No text content released.
